| Gene symbol | GPRC5D | Synonyms | None | Type of gene | protein-coding |
| Chromosome | 12 | Map location | 12p13.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | G protein-coupled receptor class C group 5 member D | ||||
| GTO ID | GTC3874 |
| Trial ID | NCT06407947 |
| Disease | Multiple Myeloma |
| Altered gene | GPRC5D |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CT071 |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | Exploratory Clinical Trial of the Safety and Efficacy of CT071 Injection in Patients With High Risk Newly Diagnosed Multiple Myeloma |
| Year | 2024 |
| Country | China |
| Company sponsor | Shanghai Changzheng Hospital |
| Other ID(s) | CT071-CG7002 |
| Cohort 1 | |||||||
|
|||||||